Human Tumour Immunobiology
Human tumour cells possess tumour-associated antigens (TAA) not present in normal tissues.
Mononuclear cells from patients bearing tumours are capable of destroying autologous tumour cells in in vitro experiments.
Plasma or serum from the tumour-bearing patient blocks the ability of that patient’s mononuclear cells to destroy autologous tumour cells.
KeywordsMultiple Myeloma Autologous Tumour Cell Human Leukocyte Interferon Specific Immune Activity Thymosin Fraction
Unable to display preview. Download preview PDF.
- Lobuglio AF (1980) Clinical Immunotherapy. Marcel Dekker, New YorkGoogle Scholar
- MacDonald JS (1976) The immunobiology of colorectal cancer. Semin Oncol 3:421–432Google Scholar
- Stevenson GT, Laurence DJR (1975) The Immune Response to Human Tumours in Man. UICC Technical Report Series, Vol 22. UICC, GenevaGoogle Scholar
- Terry WD, Windhorst D (Eds). (1978) Immunotherapy of Cancer: Present Status of Trials in Man. Raven Press, New YorkGoogle Scholar